Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$2.25B |
| 2 |
Microsoft
MSFT
|
+$1.39B |
| 3 |
Amazon
AMZN
|
+$1.26B |
| 4 |
Apple
AAPL
|
+$1.18B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$505M |
Top Sells
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$198M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
General Motors
GM
|
+$121M |
Sector Composition
| 1 | Technology | 29.5% |
| 2 | Financials | 12.9% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Avanos Medical
AVNS
$574M
| $20.2M | ﹤0.01% |
1,012,198
+21,413
| +2% | +$426K |
|
1927
1st Source
SRCE
$1.57B
| $20.2M | ﹤0.01% |
384,352
+15,724
| +4% | +$824K |
|
|
HIBB
1928
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $20.1M | ﹤0.01% |
261,712
-6,343
| -2% | -$487K |
|
1929
REX American Resources
REX
$1.01B
| $20.1M | ﹤0.01% |
341,820
+11,671
| +4% | +$685K |
|
1930
Regenxbio
RGNX
$470M
| $20M | ﹤0.01% |
950,551
+20,879
| +2% | +$440K |
|
1931
Deluxe
DLX
$883M
| $20M | ﹤0.01% |
972,259
+28,024
| +3% | +$577K |
|
|
BRKL
1932
DELISTED
Brookline Bancorp
BRKL
| $19.9M | ﹤0.01% |
2,000,462
+57,384
| +3% | +$572K |
|
1933
Metallus
MTUS
$702M
| $19.8M | ﹤0.01% |
890,423
+13,343
| +2% | +$297K |
|
1934
Repay Holdings
RPAY
$510M
| $19.8M | ﹤0.01% |
1,798,479
+46,603
| +3% | +$513K |
|
1935
Energy Recovery
ERII
$762M
| $19.8M | ﹤0.01% |
1,253,115
+37,064
| +3% | +$585K |
|
1936
PC Connection
CNXN
$1.6B
| $19.8M | ﹤0.01% |
300,074
+9,107
| +3% | +$600K |
|
1937
Vir Biotechnology
VIR
$704M
| $19.7M | ﹤0.01% |
1,949,189
+62,793
| +3% | +$636K |
|
1938
Kaspi.kz JSC
KSPI
$16.1B
| $19.7M | ﹤0.01% |
+153,500
| New | +$19.7M |
|
1939
Origin Bancorp
OBK
$1.11B
| $19.7M | ﹤0.01% |
631,868
+12,297
| +2% | +$384K |
|
|
DCPH
1940
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $19.7M | ﹤0.01% |
1,254,317
+33,009
| +3% | +$519K |
|
1941
TechTarget
TTGT
$428M
| $19.7M | ﹤0.01% |
594,689
+23,941
| +4% | +$792K |
|
1942
eXp World Holdings
EXPI
$1.78B
| $19.6M | ﹤0.01% |
1,899,569
+45,176
| +2% | +$467K |
|
1943
N-able
NABL
$1.55B
| $19.6M | ﹤0.01% |
1,499,325
+33,590
| +2% | +$439K |
|
|
PGRE
1944
Paramount Group
PGRE
$1.59B
| $19.6M | ﹤0.01% |
4,177,797
+75,078
| +2% | +$352K |
|
1945
Arcutis Biotherapeutics
ARQT
$2.05B
| $19.5M | ﹤0.01% |
1,971,433
+227,844
| +13% | +$2.26M |
|
1946
B&G Foods
BGS
$364M
| $19.5M | ﹤0.01% |
1,707,800
+118,696
| +7% | +$1.36M |
|
1947
Vicor
VICR
$2.28B
| $19.5M | ﹤0.01% |
509,398
+12,272
| +2% | +$469K |
|
1948
Sabre
SABR
$730M
| $19.5M | ﹤0.01% |
8,038,151
+156,151
| +2% | +$378K |
|
1949
Shenandoah Telecom
SHEN
$751M
| $19.4M | ﹤0.01% |
1,117,217
+24,910
| +2% | +$433K |
|
1950
Couchbase
BASE
$1.35B
| $19.4M | ﹤0.01% |
737,550
+30,065
| +4% | +$791K |
|